Personalized approach in the diagnosis of thrombophilia Individualized healthcare in clotting disorders has been, and will continue to be, at the forefront in the movement of personalized medicine.

Both agencies are cautioning against a once-daily administration "in patients with thrombophilia", where "a twice daily administration of nadroparin should be considered", instead. It follows ...